Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956095070> ?p ?o ?g. }
- W2956095070 endingPage "1230" @default.
- W2956095070 startingPage "1230" @default.
- W2956095070 abstract "<h3>Importance</h3> Federal legislation proposes requiring that screening mammography reports to practitioners and women incorporate breast density information and that women with dense breasts discuss supplemental imaging with their practitioner given their increased risk of interval breast cancer. Instead of discussing supplemental imaging with all women with dense breasts, it may be more efficient to identify women at high risk of advanced breast cancer who may benefit most from supplemental imaging. <h3>Objective</h3> To identify women at high risk of advanced breast cancer to target woman-practitioner discussions about the need for supplemental imaging. <h3>Design, Setting, and Participants</h3> This prospective cohort study assessed 638 856 women aged 40 to 74 years who had 1 693 163 screening digital mammograms taken at Breast Cancer Surveillance Consortium (BCSC) imaging facilities from January 3, 2005, to December 31, 2014. Data analysis was performed from October 10, 2018, to March 20, 2019. <h3>Exposures</h3> Breast Imaging Reporting and Data System (BI-RADS) breast density and BCSC 5-year breast cancer risk. <h3>Main Outcomes and Measures</h3> Advanced breast cancer (stage IIB or higher) within 12 months of screening mammography; high advanced cancer rates (≥0.61 cases per 1000 mammograms) defined as the top 25th percentile of advanced cancer rates, and discussions per potential advanced cancer prevented. <h3>Results</h3> A total of 638 856 women (mean [SD] age, 56.5 [8.9] years) were included in the study. Women with dense breasts (heterogeneously or extremely dense) accounted for 47.0% of screened women and 60.0% of advanced cancers. Low advanced cancer rates (<0.61 per 1000 mammograms) occurred in 34.5% of screened women with dense breasts. High advanced breast cancer rates occurred in women with heterogeneously dense breasts and a 5-year risk of 2.5% or higher (6.0% of screened women) and those with extremely dense breasts and a 5-year risk of 1.0% or higher (6.5% of screened women). Density-risk subgroups at high advanced cancer risk comprised 12.5% of screened women and 27.1% of advanced cancers. Density-risk subgroups had the fewest supplemental imaging discussions per potential advanced cancer prevented compared with a strategy based on dense breasts (1097 vs 1866 discussions). Women with heterogeneously dense breasts and a 5-year risk less than 1.67% (21.7% of screened women) had high rates of false-positive short-interval follow-up recommendation without undergoing supplemental imaging. <h3>Conclusions and Relevance</h3> The findings suggest that breast density notification should be combined with breast cancer risk so women at highest risk for advanced cancer are targeted for supplemental imaging discussions and women at low risk are not. BI-RADS breast density combined with BCSC 5-year risk may offer a more efficient strategy for supplemental imaging discussions than targeting all women with dense breasts." @default.
- W2956095070 created "2019-07-12" @default.
- W2956095070 creator A5004918315 @default.
- W2956095070 creator A5008335692 @default.
- W2956095070 creator A5029752677 @default.
- W2956095070 creator A5031915406 @default.
- W2956095070 creator A5038929684 @default.
- W2956095070 creator A5049271778 @default.
- W2956095070 creator A5050357899 @default.
- W2956095070 creator A5071157273 @default.
- W2956095070 creator A5075750233 @default.
- W2956095070 creator A5077710776 @default.
- W2956095070 creator A5085257013 @default.
- W2956095070 date "2019-09-01" @default.
- W2956095070 modified "2023-10-16" @default.
- W2956095070 title "Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging" @default.
- W2956095070 cites W1675384869 @default.
- W2956095070 cites W1760351431 @default.
- W2956095070 cites W2013840898 @default.
- W2956095070 cites W2060895692 @default.
- W2956095070 cites W2080749309 @default.
- W2956095070 cites W2100725740 @default.
- W2956095070 cites W2101210666 @default.
- W2956095070 cites W2103327180 @default.
- W2956095070 cites W2107859602 @default.
- W2956095070 cites W2110997518 @default.
- W2956095070 cites W2111784232 @default.
- W2956095070 cites W2124653673 @default.
- W2956095070 cites W2132735969 @default.
- W2956095070 cites W2133458918 @default.
- W2956095070 cites W2135872216 @default.
- W2956095070 cites W2137040237 @default.
- W2956095070 cites W2148554069 @default.
- W2956095070 cites W2280342795 @default.
- W2956095070 cites W2283351472 @default.
- W2956095070 cites W2373456799 @default.
- W2956095070 cites W2393650053 @default.
- W2956095070 cites W2559771561 @default.
- W2956095070 cites W2560617851 @default.
- W2956095070 cites W2616240394 @default.
- W2956095070 cites W2773099418 @default.
- W2956095070 cites W2783194010 @default.
- W2956095070 cites W2783882211 @default.
- W2956095070 cites W2791081053 @default.
- W2956095070 cites W2800369655 @default.
- W2956095070 cites W2801665024 @default.
- W2956095070 cites W2807016245 @default.
- W2956095070 cites W2810124975 @default.
- W2956095070 cites W2887127593 @default.
- W2956095070 cites W2890971556 @default.
- W2956095070 cites W2925326149 @default.
- W2956095070 cites W4231529177 @default.
- W2956095070 cites W4237350777 @default.
- W2956095070 cites W4243768359 @default.
- W2956095070 cites W4255398094 @default.
- W2956095070 cites W4297820480 @default.
- W2956095070 doi "https://doi.org/10.1001/jamainternmed.2019.1758" @default.
- W2956095070 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6604099" @default.
- W2956095070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31260054" @default.
- W2956095070 hasPublicationYear "2019" @default.
- W2956095070 type Work @default.
- W2956095070 sameAs 2956095070 @default.
- W2956095070 citedByCount "38" @default.
- W2956095070 countsByYear W29560950702019 @default.
- W2956095070 countsByYear W29560950702020 @default.
- W2956095070 countsByYear W29560950702021 @default.
- W2956095070 countsByYear W29560950702022 @default.
- W2956095070 countsByYear W29560950702023 @default.
- W2956095070 crossrefType "journal-article" @default.
- W2956095070 hasAuthorship W2956095070A5004918315 @default.
- W2956095070 hasAuthorship W2956095070A5008335692 @default.
- W2956095070 hasAuthorship W2956095070A5029752677 @default.
- W2956095070 hasAuthorship W2956095070A5031915406 @default.
- W2956095070 hasAuthorship W2956095070A5038929684 @default.
- W2956095070 hasAuthorship W2956095070A5049271778 @default.
- W2956095070 hasAuthorship W2956095070A5050357899 @default.
- W2956095070 hasAuthorship W2956095070A5071157273 @default.
- W2956095070 hasAuthorship W2956095070A5075750233 @default.
- W2956095070 hasAuthorship W2956095070A5077710776 @default.
- W2956095070 hasAuthorship W2956095070A5085257013 @default.
- W2956095070 hasBestOaLocation W29560950701 @default.
- W2956095070 hasConcept C121608353 @default.
- W2956095070 hasConcept C126322002 @default.
- W2956095070 hasConcept C131872663 @default.
- W2956095070 hasConcept C143998085 @default.
- W2956095070 hasConcept C2777432617 @default.
- W2956095070 hasConcept C2778491387 @default.
- W2956095070 hasConcept C2780472235 @default.
- W2956095070 hasConcept C2781281974 @default.
- W2956095070 hasConcept C29456083 @default.
- W2956095070 hasConcept C530470458 @default.
- W2956095070 hasConcept C71924100 @default.
- W2956095070 hasConceptScore W2956095070C121608353 @default.
- W2956095070 hasConceptScore W2956095070C126322002 @default.
- W2956095070 hasConceptScore W2956095070C131872663 @default.
- W2956095070 hasConceptScore W2956095070C143998085 @default.
- W2956095070 hasConceptScore W2956095070C2777432617 @default.
- W2956095070 hasConceptScore W2956095070C2778491387 @default.